Cargando…
Novel application of metformin combined with targeted drugs on anticancer treatment
The success of targeted drug therapies for treating cancer patients has attracted broad attention both in the academic community and social society. However, rapidly developed acquired resistance is becoming a newly recognized major challenge to the continuing efficiency of these therapies. Metformi...
Autores principales: | Deng, Jun, Peng, Mei, Wang, Zhiren, Zhou, Sichun, Xiao, Di, Deng, Jiating, Yang, Xue, Peng, Jingyuan, Yang, Xiaoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317954/ https://www.ncbi.nlm.nih.gov/pubmed/30358009 http://dx.doi.org/10.1111/cas.13849 |
Ejemplares similares
-
Metformin targets Clusterin to control lipogenesis and inhibit the growth of bladder cancer cells through SREBP-1c/FASN axis
por: Deng, Jun, et al.
Publicado: (2021) -
The role of pyruvate kinase M2 in anticancer therapeutic treatments
por: Su, Qiongli, et al.
Publicado: (2019) -
Down‐regulation of PKM2 enhances anticancer efficiency of THP on bladder cancer
por: Su, Qiongli, et al.
Publicado: (2018) -
The role of Clusterin in cancer metastasis
por: Peng, Mei, et al.
Publicado: (2019) -
Inhibitory role of proguanil on the growth of bladder cancer via enhancing EGFR degradation and inhibiting its downstream signaling pathway to induce autophagy
por: Xiao, Di, et al.
Publicado: (2022)